Oral cefadroxil prophylaxis in hip fracture surgery: Serum concentrations studied in 17 patients

Serum concentration-time curves were determined in seventeen 82 (60-90) year-old patients undergoing trochanteric hip fracture surgery after receiving 1 g of cefadroxil per os. All the patients attained a serum level of antibiotic high enough to inhibit the growth of Staphylococcus aureus and S. epi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta orthopaedica Scandinavica 1992-02, Vol.63 (1), p.4-6
Hauptverfasser: Nungu, Kitugi Samwel, Bengtsson, Stellan, Olerud, Claes, Rehnberg, Lars, Larsson, Sune
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6
container_issue 1
container_start_page 4
container_title Acta orthopaedica Scandinavica
container_volume 63
creator Nungu, Kitugi Samwel
Bengtsson, Stellan
Olerud, Claes
Rehnberg, Lars
Larsson, Sune
description Serum concentration-time curves were determined in seventeen 82 (60-90) year-old patients undergoing trochanteric hip fracture surgery after receiving 1 g of cefadroxil per os. All the patients attained a serum level of antibiotic high enough to inhibit the growth of Staphylococcus aureus and S. epidermidis. When orally administered, cefadroxil should be given within 2 hours before surgery. Serum concentrations studied in 17 patients
doi_str_mv 10.3109/17453679209154839
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_1738968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72805160</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-4692ad4013f4e760b6227c5fc736b4f5e9a291f88eaa89bdefd1f1e4bb6bb9cc3</originalsourceid><addsrcrecordid>eNp1kEtLxDAUhbNQxnH0B7gQuhB31dwmTRpwI4MvGJiNrkuSJk4kfZi0aP-9HWbUhbi6XM53DoeD0BngKwJYXAOnOWFcZFhATgsiDtAcYwwpoxwfoeMY37YvMD5DM-CkEKyYI7IO0ifaWFmF9tP5pAtttxm9_HQxcU2ycV1ig9T9EEwSh_BqwniCDq300Zzu7wK93N89Lx_T1frhaXm7SjXJaZ9SJjJZUQzEUsMZVizLuM6t5oQpanMjZCbAFoWRshCqMrYCC4YqxZQSWpMFutzlTp3eBxP7snZRG-9lY9ohljwrcA4MTyDsQB3aGIOxZRdcLcNYAi6345R_xpk85_vwQdWm-nXslpn0i70uo5Z-2qDRLv5gOQAGscVudphrbBtq-dEGX5W9HH0bvj3k_xZfKu-A9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72805160</pqid></control><display><type>article</type><title>Oral cefadroxil prophylaxis in hip fracture surgery: Serum concentrations studied in 17 patients</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Nungu, Kitugi Samwel ; Bengtsson, Stellan ; Olerud, Claes ; Rehnberg, Lars ; Larsson, Sune</creator><creatorcontrib>Nungu, Kitugi Samwel ; Bengtsson, Stellan ; Olerud, Claes ; Rehnberg, Lars ; Larsson, Sune</creatorcontrib><description>Serum concentration-time curves were determined in seventeen 82 (60-90) year-old patients undergoing trochanteric hip fracture surgery after receiving 1 g of cefadroxil per os. All the patients attained a serum level of antibiotic high enough to inhibit the growth of Staphylococcus aureus and S. epidermidis. When orally administered, cefadroxil should be given within 2 hours before surgery. Serum concentrations studied in 17 patients</description><identifier>ISSN: 0001-6470</identifier><identifier>DOI: 10.3109/17453679209154839</identifier><identifier>PMID: 1738968</identifier><identifier>CODEN: AOSAAK</identifier><language>eng</language><publisher>Basingstoke: Taylor &amp; Francis</publisher><subject>Aged ; Aged, 80 and over ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Cefadroxil - blood ; Cefadroxil - therapeutic use ; Female ; Hip Fractures - surgery ; Humans ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Premedication ; Staphylococcus aureus - drug effects ; Staphylococcus epidermidis - drug effects ; Surgical Wound Infection - prevention &amp; control ; Time Factors</subject><ispartof>Acta orthopaedica Scandinavica, 1992-02, Vol.63 (1), p.4-6</ispartof><rights>1992 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1992</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c354t-4692ad4013f4e760b6227c5fc736b4f5e9a291f88eaa89bdefd1f1e4bb6bb9cc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5110198$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1738968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nungu, Kitugi Samwel</creatorcontrib><creatorcontrib>Bengtsson, Stellan</creatorcontrib><creatorcontrib>Olerud, Claes</creatorcontrib><creatorcontrib>Rehnberg, Lars</creatorcontrib><creatorcontrib>Larsson, Sune</creatorcontrib><title>Oral cefadroxil prophylaxis in hip fracture surgery: Serum concentrations studied in 17 patients</title><title>Acta orthopaedica Scandinavica</title><addtitle>Acta Orthop Scand</addtitle><description>Serum concentration-time curves were determined in seventeen 82 (60-90) year-old patients undergoing trochanteric hip fracture surgery after receiving 1 g of cefadroxil per os. All the patients attained a serum level of antibiotic high enough to inhibit the growth of Staphylococcus aureus and S. epidermidis. When orally administered, cefadroxil should be given within 2 hours before surgery. Serum concentrations studied in 17 patients</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Cefadroxil - blood</subject><subject>Cefadroxil - therapeutic use</subject><subject>Female</subject><subject>Hip Fractures - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Premedication</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus epidermidis - drug effects</subject><subject>Surgical Wound Infection - prevention &amp; control</subject><subject>Time Factors</subject><issn>0001-6470</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtLxDAUhbNQxnH0B7gQuhB31dwmTRpwI4MvGJiNrkuSJk4kfZi0aP-9HWbUhbi6XM53DoeD0BngKwJYXAOnOWFcZFhATgsiDtAcYwwpoxwfoeMY37YvMD5DM-CkEKyYI7IO0ifaWFmF9tP5pAtttxm9_HQxcU2ycV1ig9T9EEwSh_BqwniCDq300Zzu7wK93N89Lx_T1frhaXm7SjXJaZ9SJjJZUQzEUsMZVizLuM6t5oQpanMjZCbAFoWRshCqMrYCC4YqxZQSWpMFutzlTp3eBxP7snZRG-9lY9ohljwrcA4MTyDsQB3aGIOxZRdcLcNYAi6345R_xpk85_vwQdWm-nXslpn0i70uo5Z-2qDRLv5gOQAGscVudphrbBtq-dEGX5W9HH0bvj3k_xZfKu-A9A</recordid><startdate>19920201</startdate><enddate>19920201</enddate><creator>Nungu, Kitugi Samwel</creator><creator>Bengtsson, Stellan</creator><creator>Olerud, Claes</creator><creator>Rehnberg, Lars</creator><creator>Larsson, Sune</creator><general>Taylor &amp; Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19920201</creationdate><title>Oral cefadroxil prophylaxis in hip fracture surgery</title><author>Nungu, Kitugi Samwel ; Bengtsson, Stellan ; Olerud, Claes ; Rehnberg, Lars ; Larsson, Sune</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-4692ad4013f4e760b6227c5fc736b4f5e9a291f88eaa89bdefd1f1e4bb6bb9cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Cefadroxil - blood</topic><topic>Cefadroxil - therapeutic use</topic><topic>Female</topic><topic>Hip Fractures - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Premedication</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus epidermidis - drug effects</topic><topic>Surgical Wound Infection - prevention &amp; control</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nungu, Kitugi Samwel</creatorcontrib><creatorcontrib>Bengtsson, Stellan</creatorcontrib><creatorcontrib>Olerud, Claes</creatorcontrib><creatorcontrib>Rehnberg, Lars</creatorcontrib><creatorcontrib>Larsson, Sune</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta orthopaedica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nungu, Kitugi Samwel</au><au>Bengtsson, Stellan</au><au>Olerud, Claes</au><au>Rehnberg, Lars</au><au>Larsson, Sune</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral cefadroxil prophylaxis in hip fracture surgery: Serum concentrations studied in 17 patients</atitle><jtitle>Acta orthopaedica Scandinavica</jtitle><addtitle>Acta Orthop Scand</addtitle><date>1992-02-01</date><risdate>1992</risdate><volume>63</volume><issue>1</issue><spage>4</spage><epage>6</epage><pages>4-6</pages><issn>0001-6470</issn><coden>AOSAAK</coden><abstract>Serum concentration-time curves were determined in seventeen 82 (60-90) year-old patients undergoing trochanteric hip fracture surgery after receiving 1 g of cefadroxil per os. All the patients attained a serum level of antibiotic high enough to inhibit the growth of Staphylococcus aureus and S. epidermidis. When orally administered, cefadroxil should be given within 2 hours before surgery. Serum concentrations studied in 17 patients</abstract><cop>Basingstoke</cop><pub>Taylor &amp; Francis</pub><pmid>1738968</pmid><doi>10.3109/17453679209154839</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-6470
ispartof Acta orthopaedica Scandinavica, 1992-02, Vol.63 (1), p.4-6
issn 0001-6470
language eng
recordid cdi_pubmed_primary_1738968
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Aged, 80 and over
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Cefadroxil - blood
Cefadroxil - therapeutic use
Female
Hip Fractures - surgery
Humans
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Premedication
Staphylococcus aureus - drug effects
Staphylococcus epidermidis - drug effects
Surgical Wound Infection - prevention & control
Time Factors
title Oral cefadroxil prophylaxis in hip fracture surgery: Serum concentrations studied in 17 patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T06%3A06%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20cefadroxil%20prophylaxis%20in%20hip%20fracture%20surgery:%20Serum%20concentrations%20studied%20in%2017%20patients&rft.jtitle=Acta%20orthopaedica%20Scandinavica&rft.au=Nungu,%20Kitugi%20Samwel&rft.date=1992-02-01&rft.volume=63&rft.issue=1&rft.spage=4&rft.epage=6&rft.pages=4-6&rft.issn=0001-6470&rft.coden=AOSAAK&rft_id=info:doi/10.3109/17453679209154839&rft_dat=%3Cproquest_pubme%3E72805160%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72805160&rft_id=info:pmid/1738968&rfr_iscdi=true